Skip to content
Newsroom
Careers
Contact
(732) 640-0058
Search the website
Why Ascendia?
What We Do
Leadership
History
Technologies
LipidSol
EmulSol
AmorSol
NanoSol
Controlled Release
Services
Streamlined Development
Pre-Formulation
Formulation Development
Analytical Services
Small-Scale Formulations
ICH Stability Studies
Manufacturing
Sterile Parenteral Manufacturing
Oral, Liquid, Solid Topic Dosage Manufacturing
GMP and cGMP
Applied Clinical Trial Materials
Our Facility & Equipment
Partner with Ascendia
Search the website
Why Ascendia?
What We Do
Leadership
History
Technologies
LipidSol
EmulSol
AmorSol
NanoSol
Controlled Release
Services
Streamlined Development
Pre-Formulation
Formulation Development
Analytical Services
Small-Scale Formulations
ICH Stability Studies
Manufacturing
Sterile Parenteral Manufacturing
Oral, Liquid, Solid Topic Dosage Manufacturing
GMP and cGMP
Applied Clinical Trial Materials
Our Facility & Equipment
Partner with Ascendia
Newsroom
Careers
Contact
(732) 640-0058
Search the website
Newsroom
CDMO Platform Technologies as They Impact Dosage Formulation Solutions
Feb 13, 2024 12:00:00 AM
